4.5 Article

Modelling patterns of clearance of HPV-16 infection and vaccination efficacy

Journal

VACCINE
Volume 29, Issue 6, Pages 1270-1277

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.11.082

Keywords

Human Papillomavirus; Vaccination; Mathematical modelling

Funding

  1. Compagnia San Paolo-FIRMS (Center for Experimental Research and Medical Studies)
  2. Regione Piemonte Italy, Assessorato Sanita, Progetti di Ricerca Sanitaria Finalizzata
  3. Sanofi Pasteur MSD
  4. Merck
  5. GSK
  6. Medical Research Council [G0801056B] Funding Source: researchfish

Ask authors/readers for more resources

A model representing carcinogenic HPV infection transmission dynamics and cervical cancer natural history was adapted to assess the consequences of introducing vaccination against HPV-16 infection. Alternative scenarios either allowing repeated infections with the HPV-16 (i.e. SIS scenario) or assuming that clearance of infection occurs through the development of a long lasting, specific immune response which protects against re-infection (i.e. SIR scenario) were investigated. The difference in reduction in lifetime cervical cancer achieved through vaccination of 12-year-old girls, between SIS and SIR scenarios, was up to 25% of expected cases in an unscreened population. This difference increased to 30% when vaccination of 12-year-old boys was also included as an intervention. The role of SIS or SIR dynamics should be accounted for in the assessment of model-based projections of the effectiveness of vaccination programmes, until available data about the transmission dynamics support the accuracy of model predictions. (C) 2010 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available